Hannu J Penttilä, MD, Martti V

Slides:

Advertisements

Similar presentations

Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting Bülent Tünerir, MD, Ömer Çolak, MD,

Advertisements

Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts Hannu I Manninen,

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations Zhong-Kai Wu, MD, PhD, Jari Laurikka, MD, PhD, Antti Saraste, MD, PhD, Ville.

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Definition of proximal anastomosis in the doors study

Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting Y.John Gu, Massimo A Mariani, Willem.

Cannulation of the axillary artery for cardiopulmonary bypass: safeguards and pitfalls Michael C Sinclair, MD, Raymond L Singer, MD, Norman J Manley,

Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts Hannu I Manninen,

An experimental model of saphenous vein-to-coronary artery anastomosis with the St. Jude medical stainless steel connector Hartzell V Schaff, MD, Kenton.

PH-Stat Versus α-Stat Acid–Base Management Strategy During Hypothermic Circulatory Arrest Combined With Embolic Brain Injury Sebastian Dahlbacka, MS,

Failure of internal thoracic artery grafts: conclusions from coronary angiography mid- term follow-up Eric Bezon, MD, Jean N Choplain, MD, Yasser A Maguid,

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Is kidney function altered by the duration of cardiopulmonary bypass?

Penehyclidine hydrochloride preserves the intestinal barrier function in patients undergoing cardiopulmonary bypass Ying-jie Sun, PhD, Dan-dan Song,

Coronary artery operation in patients after breast cancer therapy

Metabolic and Hemodynamic Effects of High-Dose Insulin Treatment in Aortic Valve and Coronary Surgery Juha K. Koskenkari, MD, Päivi K. Kaukoranta, MD,

Cardiac troponin I release after open heart surgery: a marker of myocardial protection? Emmanuelle Vermes, MD, Martine Mesguich, MD, Rémi Houel, MD, Céline.

Comparison of troponin-I and troponin-T after pediatric cardiovascular operation Franz F Immer, MD, Franco P Stocker, MD, Andrea M Seiler, MD, Jean-Pierre.

François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD

How safe is the port access technique in minimally invasive coronary artery bypass grafting? Selami Dogan, MD, Kai Graubitz, MD, Tayfun Aybek, MD, Mohammad.

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass–induced injury Maurice Beghetti, MD, Philip E Silkoff, Marlova Caramori, MD,

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Improved Cerebral Recovery From Hypothermic Circulatory Arrest After Remote Ischemic Preconditioning Fredrik S. Yannopoulos, MB, Tuomas Mäkelä, MB, Eija.

Hannu J Penttilä, MD, Martti V

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting Saara M Weman, MD, Pekka J Karhunen, MD, Antti Penttilä,

Continuous cold blood cardioplegia improves myocardial protection: a prospective randomized study Yves A.G Louagie, MD, PhD, Jacques Jamart, MD, Manuel.

Michel Carrier, MD, Michel Pellerin, MD, Louis P Perrault, MD, PhD, B

Ischemic preconditioning does not improve myocardial preservation during off-pump multivessel coronary operation Hannu J Penttilä, MD, Martti V.K Lepojärvi,

Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Eeva-Maija.

Kai Ihnken, MD The Journal of Thoracic and Cardiovascular Surgery

Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting Josef.

Mudassir I Dar, Timothy Gillott, Franco Ciulli, MD, Graham J Cooper

Initial experience with sutureless proximal anastomoses performed with a mechanical connector leading to clampless off-pump coronary artery bypass surgery

Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting Zhong-Kai Wu, MD, Matti R Tarkka,

Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: A randomized prospective.

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery Reza Motallebzadeh, MRCS, J.

Michael W. A. Chu, MD, Steve R. Wilson, BS, Richard J

Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass Sudip Ghosh, MD, Manuel Galiñanes,

Early markers of major adverse events in children after cardiac operations Trevor Duke, FRACPa, Warwick Butt, FRACPa, Mike South, MD, FRACPb, Tom R. Karl,

Levels of Troponin I and Cardiac Enzymes After Reinfusion of Shed Blood in Coronary Operations Ruggero De Paulis, MD, Luisa Colagrande, MD, Francesco.

Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost Michael J Ray, PhD, Mark F O’Brien

Kagami Miyaji, MD, Randall K Wolf, MD, John B Flege, MD

F.Paget Milsom, Simon J Mitchell, MB The Annals of Thoracic Surgery

Markers of myocardial ischemia after minimally invasive and conventional coronary operation Erich Kilger, MD, Bodo Pichler, MD, Florian Weis, MD, Alwin.

Intermittent Warm Blood Cardioplegia Preserves Myocardial β-Adrenergic Receptor Function Massimo Chello, Pasquale Mastroroberto, Vincenzo De Amicis,

Adam E Saltman, MD, PhD, Walter H Dzik, MD, Sidney Levitsky, MD

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations Zhong-Kai Wu, MD, PhD, Jari Laurikka, MD, PhD, Antti Saraste, MD, PhD, Ville.

Computer-assisted endoscopic coronary artery bypass anastomoses: a chronic animal study Edward R Stephenson, MD, Christopher T Ducko, MD, Sachin Sankholkar,

Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit Michael J Ray, PhD, Majella M Hales,

Serum S100β release after coronary artery bypass grafting: roller versus centrifugal pump Saeed Ashraf, Kausik Bhattacharya, Sunny Zacharias, Pradeep.

Sérgio A de Oliveira, MD The Annals of Thoracic Surgery

Robert R Lazzara, MD, Francis E Kidwell, BS

Sequential Bypass Grafting on the Beating Heart: Blood Flow Characteristics Marek Gwozdziewicz, MD, PhD, Petr Němec, MD, PhD, Martin Šimek, MD, Roman.

Willem J.L. Suyker, MD, Cornelius Borst, MD, PhD

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations Wulf Dietrich, Karl Schöpf, Michael Spannagl, Marianne.

Invited commentary The Annals of Thoracic Surgery

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass Peter Raivio, MD, Jari Petäjä,

Direct repair of giant right coronary aneurysm

Presentation transcript:

Myocardial preservation during coronary surgery with and without cardiopulmonary bypass Hannu J Penttilä, MD, Martti V.K Lepojärvi, MD, Kai T Kiviluoma, MD, Päivi K Kaukoranta, MD, Ilmo E Hassinen, MD, Keijo J Peuhkurinen, MD The Annals of Thoracic Surgery Volume 71, Issue 2, Pages 565-570 (February 2001) DOI: 10.1016/S0003-4975(00)02002-6

Fig 1 Study design and blood sampling schedule. T0= before bypass grafting; T1–T2= immediately after the first two distal anastomoses; T3–T4= 5 and 15 minutes after the suturing of the last anastomosis; T5–T6= 2 and 8 hours after the suturing of the last anastomosis; T7–T10= On the first to fourth postoperative day. The Annals of Thoracic Surgery 2001 71, 565-570DOI: (10.1016/S0003-4975(00)02002-6)

Fig 2 Myocardial lactate production (A) and transcardiac pH difference (B) (median, 25% and 75% percentiles, and nonoutlier range) before bypass (T0), after the completition of the first (T1) and second (T2) distal anastomoses, and 5 (T3) and 15 (T4) minutes after the suturing of the last anastomosis. The increases in myocardial lactate production (p = 0.002 with CPB, and p = 0.04 without CPB) and the transcardiac pH difference (p < 0.001) were significant in both groups. The letters a, b, c, and d indicate the differences between the groups (p = 0.02, p = 0.01, p = 0.007, and p < 0.001, respectively). The Annals of Thoracic Surgery 2001 71, 565-570DOI: (10.1016/S0003-4975(00)02002-6)

Fig 3 Plasma levels of CK-MB mass (A) and Troponin I (B) (median, 25% and 75% percentiles, and nonoutlier range) before the construction of the anastomoses (T0), at 2 (T5) and 8 (T6) hours after the suturing of the last anastomosis, and on the next 4 days (T7–T10). The increases in both myocardial markers were statistically significant in both groups (p ≤ 0.001). The letters a, b, c, d, and e indicate significant differences between the groups (p < 0.001, p = 0.002, p = 0.04, p = 0.002, and p = 0.008, respectively). The Annals of Thoracic Surgery 2001 71, 565-570DOI: (10.1016/S0003-4975(00)02002-6)